NCT06959836View on ClinicalTrials.gov

Post-market Safety and Performance Outcomes of the VIVERE® Bovine Pericardial Bioprosthetic Valve

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

April 1, 2025

Conditions
AORTIC VALVE DISEASESAortic Valve Stenosis and InsufficiencyAortic Valve SurgeryMitral Valve RegurgitationMitral Valve Surgery
Interventions
DEVICE

VIVERE Bovine Pericardial Bioprosthetic Valve

Replacement of the native valve or bioprosthesis

Trial Locations (3)

14780-360

Hospital Nossa Senhora (Fundação Pio Xii), Barretos

13201-625

Hospital de Caridade São Vicente de Paulo, Jundiaí

15015-750

Hospital Beneficência Portuguesa, São José do Rio Preto

All Listed Sponsors
lead

Braile Biomedica Ind. Com. e Repr. Ltda.

INDUSTRY

NCT06959836 - Post-market Safety and Performance Outcomes of the VIVERE® Bovine Pericardial Bioprosthetic Valve | Biotech Hunter | Biotech Hunter